Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
USP Workshop on Thresholds and Best Practices for Parenteral and Ophthalmic Drug Products Bethesda, MD February 22 and 23, 2011
Presenter
A single-dose injection that is intended for intravenous use and is packaged in containers labeled as containing more than 100 mL.
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
Characteristics of LVPs
Packaged in glass bottles or in large volume flexible containers. May contain greater than 100 ml to greater than 1 or 2 L Sterile Pyrogen-Free Essentially free of particulate matter No anti-microbial agents Isotonicity
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
Route of Administration
Intravenous Direct Injection Infusion Subcutaneous Intramuscular Intradermal Intraspinal Intrathecal Intra-arterial Others
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
A
A. From http://www.wirralchesterkidney.nhs.uk/images/principle.jpg
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
Materials of Construction
Basic Types of Plastics Thermoplastics Polymers that soften upon heating and solidify upon cooling Most parenteral packaging Thermosets Chemically reactive polymers in the fluid state Harden irreversibly by cross-linking Epoxies, melamine resins, cross-linked polyesters and phenolics
10
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
11
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
12
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
13
Disadvantages Permeation of vapors and other molecules in either direction through the walls. Resolved by overwrapping the containers. Leaching of constituents from the plastic into the product. Plasticizers and anti-oxidants Sorption of drug molecules or ions on the plastic material. Proteins, warfarin sodium, diazepam
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
14
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
15
16
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
17
Ethylene Oxide (EtO) May be used for the empty container and then aseptically filled. Must evaluate possible residues and degradants from EtO.
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
18
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
Possible Extractables
Plastics Antioxidants: BHT, thioesters, phosphates Lubricants: silicones, polyethylene waxes Plasticizers: phthalates Glass Major extractables: silicon and sodium Minor extractables: K, Ca, Ba, Al Trace extractables: Fe, Mg, Zn Dependant upon pH, buffer, and other components in formulation
19
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.
Summary
Contain >100 mL, no antimicrobial agents Typically simple solutions NaCl, Dextrose, other nutritional solutions Available in glass and flexible containers Trend toward multi-chamber bags Available for infusions, dialysis, irrigation Plastic films chosen based on flexibility, resistance to moisture permeation, ability to sterilize
20
2010 Baxter International Inc. Baxter is a registered trademark of Baxter International Inc.